VHOSPITAL.CLINIC · Differential Diagnosis
Guillain-Barré Syndrome vs Multiple Sclerosis
Clinical comparison — shared symptoms, key differences, distinguishing diagnostic tests, treatment pathways, and when to seek urgent evaluation.
Condition Overview
Condition A
Guillain-Barré Syndrome
Guillain-Barré syndrome is an acute autoimmune polyneuropathy typically triggered by infection, causing rapidly ascending muscle weakness that can lead to respiratory paralysis. Most patients recover with immunotherapy (IVIG or plasmapheresis).
Condition B
Multiple Sclerosis
Multiple sclerosis is a chronic autoimmune disease in which the immune system attacks the myelin sheath of nerve fibers in the central nervous system. It causes episodes of neurological symptoms including vision loss, muscle weakness, balance problems, and cognitive changes.
Shared Symptoms — Why They're Confused
Both conditions present with 4 overlapping symptoms, making clinical differentiation essential.
Key Clinical Differences
Guillain-Barré Syndrome
- Ascending flaccid paralysis following infection (Campylobacter, viral)
- Areflexia — hallmark finding
- Acute onset over days to 4 weeks
- CSF: albuminocytological dissociation (high protein, normal cells)
Multiple Sclerosis
- Relapsing-remitting neurological deficits — weeks to months apart
- Upper motor neuron signs: spasticity, hyperreflexia
- Optic neuritis, sensory disturbance, fatigue
- MRI: demyelinating plaques
Distinguishing Diagnostic Tests
| Test | Guillain-Barré Syndrome | Multiple Sclerosis |
|---|---|---|
| Nerve conduction studies (NCS) | Demyelinating pattern (reduced conduction velocity), absent F-waves | Normal or mild slowing — MS is central (brain/cord), not peripheral nerve |
| Deep tendon reflexes | Absent or markedly reduced — lower motor neuron | Brisk or hyperreflexic — upper motor neuron |
| CSF analysis | Elevated protein (>0.45 g/L), normal or minimal cell count | Oligoclonal bands; mild lymphocytosis; near-normal protein |
Treatment Approaches
Guillain-Barré Syndrome
- •IV immunoglobulin (IVIG) or plasmapheresis
- •Respiratory monitoring (FVC) and ITU support if needed
- •Physiotherapy for recovery
Multiple Sclerosis
- •Disease-modifying therapies (interferon, natalizumab, ocrelizumab)
- •IV steroids for relapses
- •Symptom management: spasticity, bladder, fatigue
When Doctors Consider Each Diagnosis
🔵 Consider Guillain-Barré Syndrome when:
- →Ascending paralysis after infection, areflexia, CSF high protein, NCS demyelination
🟢 Consider Multiple Sclerosis when:
- →Relapsing-remitting course, UMN signs, MRI plaques, oligoclonal bands
Explore Each Condition in Detail
Related Clinical Pages
Guillain-Barré Syndrome
Medical References
Content on this page is informed by evidence-based clinical sources including:
- World Health Organization (WHO)Global health guidance and disease classification
- National Health Service (NHS)UK clinical guidelines and patient information
- National Institute for Health and Care Excellence (NICE)Evidence-based clinical practice guidelines
- Centers for Disease Control and Prevention (CDC)US public health data and clinical recommendations
- PubMed – NCBIPeer-reviewed biomedical literature and clinical studies
- Cochrane LibrarySystematic reviews and meta-analyses in evidence-based medicine
Not sure which condition applies to you?
Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →